UPDATE: EPO Upholds Molecular Devices Patent with Amendments | GenomeWeb

a GenomeWeb staff reporter

This story has been updated to include comments from Nanion Technologies.

NEW YORK (GenomeWeb News) — The European Patent Office has upheld Molecular Devices' foundation planar patch-clamp patent, but with amendments, ending a dispute filed against the patent by Nanion Technologies.

The ruling is final and cannot be appealed. The EPO will issue a written decision in the near future, Molecular Devices said in a statement issued on Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.